BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi X, Yuan X, Tao D, Gong J, Hu G. Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry. J Huazhong Univ Sci Technolog Med Sci. 2005;25:198-201. [PMID: 16116972 DOI: 10.1007/bf02873576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Nugroho PS, Yusuf M, Hidayati TA. Correlation between Cell Proliferation with Cervical Lymphoid Node Status in Nasopharyngeal Carcinoma Patients. FMI 2021;57:20. [DOI: 10.20473/fmi.v57i1.8765] [Reference Citation Analysis]
2 Li M, Pu XY, Dong LH, Chang PY. Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681 [PMID: 33728312 DOI: 10.12998/wjcc.v9.i7.1676] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Emara NM, Abd El-maksoud AA, Ibrahim E, Zeidan AM, Nouh AM. Prognostic value of claudin-4, nm23-H1, and MIB-1 in undifferentiated nasopharyngeal carcinoma. Egyptian Journal of Pathology 2016;36:149-157. [DOI: 10.1097/01.xej.0000504533.36954.32] [Reference Citation Analysis]
4 Zhao LP, Xue C, Zhang JW, Hu ZH, Zhao YY, Zhang J, Huang Y, Zhao HY, Zhang L. Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma. Chin J Cancer 2012;31:476-83. [PMID: 22692073 DOI: 10.5732/cjc.012.10029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zeng Y, Huang W, Yao K. Recent Advances in Nasopharyngeal Carcinoma Research and Its Pathogenesis. Recent Advances in Cancer Research and Therapy 2012. [DOI: 10.1016/b978-0-12-397833-2.00017-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Yu D, Zhang Y, Zou Y, Qin J, Li X, Xiao H, Tao D, Hu J, Gong J. Proliferation characteristics of CD133+ cell population in colorectal cancer. J Huazhong Univ Sci Technolog Med Sci 2010;30:751-6. [PMID: 21181366 DOI: 10.1007/s11596-010-0652-9] [Reference Citation Analysis]
7 Purvinienė R, Kazlauskaitė N, Atkočius V, Characiejus D, Lukšienė A. Relationship between growth fraction and clonogenic survival after ionizing irradiation in pancreatic MiaPaCa2 cells. Acta medica Lituanica 2009;16:42-46. [DOI: 10.2478/v10140-009-0006-8] [Reference Citation Analysis]
8 Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007;6:1. [PMID: 17199893 DOI: 10.1186/1476-4598-6-1] [Cited by in Crossref: 163] [Cited by in F6Publishing: 176] [Article Influence: 10.9] [Reference Citation Analysis]
9 Davis JE, Smith MC, Coman WB, Moss DJ. Epstein–Barr virus: the future for screening, treatment and monitoring of nasopharyngeal carcinoma. Future Virology 2006;1:211-221. [DOI: 10.2217/17460794.1.2.211] [Reference Citation Analysis]